United Kingdom· GB-APID-39799811000001105
Fintepla 2.2mg/ml oral solution
A medicinal product containing fenfluramine, registered in United Kingdom by UCB Pharma Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Fenfluramine
- Manufacturer
- UCB Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 6
- gtin05397259100007
- gtin05397259100021
- gtin5413787222513
- gtin05413787222124
- gtin05397259100038
- gtin5413787222520
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fenfluramine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFINTEPLAUCB Pharma SA, Brusel
- NorwayFinteplaUCB Pharma S.A.
- ItalyFINTEPLA*os soluz 120 ml 2,2 mg/ml + 1 adattatore per flacone + 2 sir 3 ml + 2 sir 6 mlUCB PHARMA S.A.
- SwitzerlandFintepla 2.2 mg/ml, solution buvableUCB-Pharma SA
- IrelandFintepla 2.2 mg/ml oral solutionUCB Pharma S.A.
- IcelandFinteplaUCB Pharma S.A.*
- Japanフェンフルラミン塩酸塩日本新薬
- NetherlandsFintepla 2,2 mg/ml drankUCB Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fintepla
- Liechtenstein · Fintepla
- Norway · Fintepla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4cc09047-3ce4-45de-ae68-43aa81eed1e8 GET /v1/drugs/4cc09047-3ce4-45de-ae68-43aa81eed1e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39799811000001105",
"desc": "Fintepla 2.2mg/ml oral solution (UCB Pharma Ltd)",
"form": "Oral solution",
"vpid": "39803911000001103",
"source": "dmd",
"vtm_id": "775927004",
"strength": "2.2 mg",
"substance": "Fenfluramine",
"ingredient": "Fenfluramine hydrochloride",
"supplier_code": "2089701000001105"
}See everything about fenfluramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.